Chemokine receptor expression in multiple myeloma

Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations.

British journal of haematology·2021

Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group.

The Lancet. Oncology·2021

Allogeneic transplantation in multiple myeloma: long-term follow-up and cytogenetic subgroup analysis.

Leukemia·2019

Effects of single-agent bortezomib as post-transplant consolidation therapy on multiple myeloma-related bone disease: a randomized phase II study.

British journal of haematology·2017

Autotransplant with and without induction chemotherapy in older multiple myeloma patients: long-term outcome of a randomized trial.

Haematologica·2016

European Myeloma Network guidelines for the management of multiple myeloma-related complications.

Haematologica·2015

Decreasing excess mortality after allogeneic stem cell transplantation for acute leukemia.

Haematologica·2026

Risks and benefits of gene therapy and transplantation in sickle cell disease. Comment on: "HLA-haploidentical hematopoietic stem cell transplantation in patients with sickle cell disease: results from the phase II DREP-HAPLO trial"

Haematologica·2026

Balancing remission durability and treatment burden in older acute myeloid leukemia. Comment on: "Long-term follow-up of oral decitabine/cedazuridine plus venetoclax for older or unfit patients with newly diagnosed acute myeloid leukemia".

Haematologica·2026

Separating dose schedule from disease biology in CD19 CAR T-cell therapy. Comment on: "A novel dose-dense strategy for CD19-directed CAR T-cell therapy is associated with durable responses without increased toxicity in patients with B-cell non-Hodgkin lymphoma".

Haematologica·2026

Safety, feasibility, and efficacy of anti-PD-1 therapy for the treatment of classical Hodgkin lymphoma.

Haematologica·2026

Defining the therapeutic window of NLRP6 modulation in graft-versus-host disease. Comment on: "NLRP6 regulates donor T cell activation and acute graft-versus-host disease via ZAP-70-Erk pathway".

Haematologica·2026

When a Mimicker Is Mimicked: A Case report on Acid-Fast Atypical Lepromatous Leprosy Mimicking Tuberculosis.

Indian journal of medical microbiology·2026

Proposed Solutions for a Multiple Myeloma Case with Unobtainable Serum.

Clinical laboratory·2026

Mitochondrial bioenergetic remodeling underlies fingolimod-induced immunometabolic adaptation in multiple sclerosis.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026

Mosaic Loss of Y Chromosome and Risks of Peripheral Arterial and Aortic Diseases.

JACC. Advances·2026

Overlapping mycoses in a case of Seborrheic dermatitis with coexistent Malassezia folliculitis.

Medical mycology case reports·2026

Correction: MAFLD is associated with lower bone mineral density in patients with type 2 diabetes: an exploratory cross-sectional analysis of a potential indirect association with HOMA-IR.

Frontiers in medicine·2026

Related Experiment Videos

Chemokine receptor expression in multiple myeloma

Related Concept Videos

Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations.

Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group.

Allogeneic transplantation in multiple myeloma: long-term follow-up and cytogenetic subgroup analysis.

Effects of single-agent bortezomib as post-transplant consolidation therapy on multiple myeloma-related bone disease: a randomized phase II study.

Autotransplant with and without induction chemotherapy in older multiple myeloma patients: long-term outcome of a randomized trial.

European Myeloma Network guidelines for the management of multiple myeloma-related complications.

Decreasing excess mortality after allogeneic stem cell transplantation for acute leukemia.

Risks and benefits of gene therapy and transplantation in sickle cell disease. Comment on: "HLA-haploidentical hematopoietic stem cell transplantation in patients with sickle cell disease: results from the phase II DREP-HAPLO trial"

Balancing remission durability and treatment burden in older acute myeloid leukemia. Comment on: "Long-term follow-up of oral decitabine/cedazuridine plus venetoclax for older or unfit patients with newly diagnosed acute myeloid leukemia".

Separating dose schedule from disease biology in CD19 CAR T-cell therapy. Comment on: "A novel dose-dense strategy for CD19-directed CAR T-cell therapy is associated with durable responses without increased toxicity in patients with B-cell non-Hodgkin lymphoma".

Safety, feasibility, and efficacy of anti-PD-1 therapy for the treatment of classical Hodgkin lymphoma.

Defining the therapeutic window of NLRP6 modulation in graft-versus-host disease. Comment on: "NLRP6 regulates donor T cell activation and acute graft-versus-host disease via ZAP-70-Erk pathway".

When a Mimicker Is Mimicked: A Case report on Acid-Fast Atypical Lepromatous Leprosy Mimicking Tuberculosis.

Proposed Solutions for a Multiple Myeloma Case with Unobtainable Serum.

Mitochondrial bioenergetic remodeling underlies fingolimod-induced immunometabolic adaptation in multiple sclerosis.

Mosaic Loss of Y Chromosome and Risks of Peripheral Arterial and Aortic Diseases.

Overlapping mycoses in a case of Seborrheic dermatitis with coexistent Malassezia folliculitis.

Correction: MAFLD is associated with lower bone mineral density in patients with type 2 diabetes: an exploratory cross-sectional analysis of a potential indirect association with HOMA-IR.

Related Experiment Videos

Chemokine receptor expression in multiple myeloma

Related Concept Videos

Related Articles